Controlling Cytomegalovirus: Helping the Immune System Take the Lead

por Hanley, Patrick J., Bollard, Catherine M.
Publicado 2014

The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of care

por Saglio, Francesco, Hanley, Patrick J., Bollard, Catherine M.
Publicado 2014

Editorial: Advances in Pediatric Hematopoietic Cell Therapies and Transplantation

por Katsanis, Emmanuel, Hanley, Patrick J., Simpson, Richard J.
Publicado 2022

Virus-Specific T Cell Therapies for HIV: Lessons Learned From Hematopoietic Stem Cell Transplantation

por Lee, Ping-Hsien, Keller, Michael D., Hanley, Patrick J., Bollard, Catherine M.
Publicado 2020

A single exercise bout enhances the manufacture of viral-specific T-cells from healthy donors: implications for allogeneic adoptive transfer immunotherapy

por Spielmann, Guillaume, Bollard, Catherine M., Kunz, Hawley, Hanley, Patrick J., Simpson, Richard J.
Publicado 2016

Influence of administration of mesenchymal stromal cell on pediatric oxygenator performance and inflammatory response

por Maeda, Takuya, Briggs, Casey M., Datar, Anushree, Brantner, Christine A., Hanley, Patrick J., Jonas, Richard A., Ishibashi, Nobuyuki
Publicado 2021

Toward a Rapid Production of Multivirus-Specific T Cells Targeting BKV, Adenovirus, CMV, and EBV from Umbilical Cord Blood

por Dave, Hema, Luo, Min, Blaney, J.W., Patel, Shabnum, Barese, Cecilia, Cruz, Conrad Russell, Shpall, Elizabeth J., Bollard, Catherine M., Hanley, Patrick J.
Publicado 2017

Emerging trends in COVID-19 treatment: learning from inflammatory conditions associated with cellular therapies

por Cancio, Maria, Ciccocioppo, Rachele, Rocco, Patricia R.M., Levine, Bruce L., Bronte, Vincenzo, Bollard, Catherine M., Weiss, Daniel, Boelens, Jaap Jan, Hanley, Patrick J.
Publicado 2020

Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against Cancer

por Patel, Shabnum, Burga, Rachel A., Powell, Allison B., Chorvinsky, Elizabeth A., Hoq, Nia, McCormack, Sarah E., Van Pelt, Stacey N., Hanley, Patrick J., Cruz, Conrad Russell Y.
Publicado 2019

HIV-Specific T Cells Can Be Generated against Non-escaped T Cell Epitopes with a GMP-Compliant Manufacturing Platform

por Patel, Shabnum, Hanajiri, Ryo, Grant, Melanie, Saunders, Devin, Van Pelt, Stacey, Keller, Michael, Hanley, Patrick J., Simon, Gary, Nixon, Douglas F., Hardy, David, Jones, R. Brad, Bollard, Catherine M.
Publicado 2019

Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIV

por Powell, Allison B., Ren, Yanqin, Korom, Maria, Saunders, Devin, Hanley, Patrick J., Goldstein, Harris, Nixon, Douglas F., Bollard, Catherine M., Lynch, Rebecca M., Jones, R. Brad, Cruz, Conrad Russell Y.
Publicado 2020

Mycobacteria-Specific T Cells May Be Expanded From Healthy Donors and Are Near Absent in Primary Immunodeficiency Disorders

por Patel, Shabnum, Lang, Haili, Sani, Gelina, Freeman, Alexandra F., Leiding, Jennifer, Hanley, Patrick J., Cruz, Conrad Russell, Grant, Melanie, Wang, Yunfei, Oshrine, Benjamin, Palmer, Cindy, Holland, Steven M., Bollard, Catherine M., Keller, Michael D.
Publicado 2019

Tumor-associated antigen–specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma

por Dave, Hema, Terpilowski, Madeline, Mai, Mimi, Toner, Keri, Grant, Melanie, Stanojevic, Maja, Lazarski, Christopher, Shibli, Abeer, Bien, Stephanie A., Maglo, Philip, Hoq, Fahmida, Schore, Reuven, Glenn, Martha, Hu, Boyu, Hanley, Patrick J., Ambinder, Richard, Bollard, Catherine M.
Publicado 2022

Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization

por Powell, Allison B., Yadavilli, Sridevi, Saunders, Devin, Van Pelt, Stacey, Chorvinsky, Elizabeth, Burga, Rachel A., Albihani, Shuroug, Hanley, Patrick J., Xu, Zhenhua, Pei, Yanxin, Yvon, Eric S., Hwang, Eugene I., Bollard, Catherine M., Nazarian, Javad, Cruz, Conrad Russell Y.
Publicado 2019

Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products

por Durkee-Shock, Jessica, Lazarski, Christopher A., Jensen-Wachspress, Mariah A., Zhang, Anqing, Son, Aran, Kankate, Vaishnavi V., Field, Naomi E., Webber, Kathleen, Lang, Haili, Conway, Susan R., Hanley, Patrick J., Bollard, Catherine M., Keller, Michael D., Schwartz, Daniella M.
Publicado 2022

Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell disease

por Kinoshita, Hannah, Mandava, Mamatha, Jensen-Wachspress, Mariah, Lang, Haili, Joy, Elisabeth, Tanna, Jay, McCann, Chase D., O’Brien, Samuel, Burnett, Sianna, Shibli, Abeer, Hoq, Fahmida, Bhatia, Monica, Hanley, Patrick J., Dávila Saldaña, Blachy, Mahadeo, Kris M., Bollard, Catherine M., Keller, Michael D., Abraham, Allistair
Publicado 2022

Scheduled administration of virus-specific T cells for viral prophylaxis after pediatric allogeneic stem cell transplant

por Rubinstein, Jeremy D., Lutzko, Carolyn, Leemhuis, Thomas, Zhu, Xiang, Pham, Giang, Ray, Lorraine, Thomas, Shawn, Dourson, Celeste, Wilhelm, Jamie, Lane, Adam, Cancelas, Jose A., Lipps, Dakota, Ferrell, Justin, Hanley, Patrick J., Keller, Michael D., Bollard, Catherine M., Wang, YunZu M., Davies, Stella M., Nelson, Adam S., Grimley, Michael S.
Publicado 2022

Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT

por Kinoshita, Hannah, Cooke, Kenneth R., Grant, Melanie, Stanojevic, Maja, Cruz, C. Russell, Keller, Michael, Fortiz, Maria Fernanda, Hoq, Fahmida, Lang, Haili, Barrett, A. John, Liang, Hua, Tanna, Jay, Zhang, Nan, Shibli, Abeer, Datar, Anushree, Fulton, Kenneth, Kukadiya, Divyesh, Zhang, Anqing, Williams, Kirsten M., Dave, Hema, Dome, Jeffrey S., Jacobsohn, David, Hanley, Patrick J., Jones, Richard J., Bollard, Catherine M.
Publicado 2022

Coronavirus-Specific T-Cells Can be Rapidly Expanded from Convalescent Donors for Potential Clinical Use

por Keller, Michael D., Harris, Katherine M., Conway, Susan, Durkee-Shock, Jessica, Jensen-Wachspress, Mariah, Kankate, Vaishnavi V, Lang, Haili, Lazarski, Christopher, Lee, Ping-Hsien, Chaudhry, Kajal, Webber, Kathleen, Datar, Anushree, Cohen, Jeffrey I., Jones, R. Brad, Cruz, Russell, Hoq, Fahmida, Bollard, Cath M., Hanley, Patrick J., Abraham, Alister, Stanojevic, Maja, Terpilowski, Madeline, Reynolds, Emily K, Stevenson, Eva, Val, Stephanie, Shancer, Zoe, Zhang, Nan, Geiger, Ashley, Liang, Hua, Dropulic, Lesia, Burbelo, Peter, Gangler, Krista
Publicado 2021

SARS-CoV-2–specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein

por Keller, Michael D., Harris, Katherine M., Jensen-Wachspress, Mariah A., Kankate, Vaishnavi V., Lang, Haili, Lazarski, Christopher A., Durkee-Shock, Jessica, Lee, Ping-Hsien, Chaudhry, Kajal, Webber, Kathleen, Datar, Anushree, Terpilowski, Madeline, Reynolds, Emily K., Stevenson, Eva M., Val, Stephanie, Shancer, Zoe, Zhang, Nan, Ulrey, Robert, Ekanem, Uduak, Stanojevic, Maja, Geiger, Ashley, Liang, Hua, Hoq, Fahmida, Abraham, Allistair A., Hanley, Patrick J., Cruz, C. Russell, Ferrer, Kathleen, Dropulic, Lesia, Gangler, Krista, Burbelo, Peter D., Jones, R. Brad, Cohen, Jeffrey I., Bollard, Catherine M.
Publicado 2020